In defence of polypharmacy

被引：40
作者：
Aronson, JK [1 ]
机构：
[1] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 57卷 / 02期
关键词：
D O I：
10.1111/j.1365-2125.2004.02067.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 6 条
  • [1] ARONSON JK, 1985, ACCOUNT FOXGLOVE ITS, P268
  • [2] Automated signal generation in prescription-event monitoring
    Heeley, E
    Wilton, LV
    Shakir, SAW
    [J]. DRUG SAFETY, 2002, 25 (06) : 423 - 432
  • [3] Association between antidepressant drug use and hyponatraemia: a case-control study
    Movig, KLL
    Leufkens, HGM
    Lenderink, AW
    van den Akker, VGA
    Hodiamont, PPG
    Goldschmidt, HMJ
    Egberts, ACG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) : 363 - 369
  • [4] The role of oral antidiabetic agents:: why and when to use an early-phase insulin secretion agent in Type 2 diabetes mellitus
    Standl, E
    Füchtenbusch, M
    [J]. DIABETOLOGIA, 2003, 46 (Suppl 1) : M30 - M36
  • [5] A strategy to reduce cardiovascular disease by more than 80%
    Wald, NJ
    Law, MR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7404): : 1419 - 1423
  • [6] Watson Gilbert., 1966, THERIAC MITHRIDATIUM
1